腫瘍学におけるコンパニオン診断テストの世界市場：市場規模・現状・予測

• 英文タイトル：Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03611 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、腫瘍学におけるコンパニオン診断テストの世界市場について調査・分析し、腫瘍学におけるコンパニオン診断テストの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（タンパク質検出、DNA検出）、用途別（製薬・バイオテクノロジー企業、医療機器企業、研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍学におけるコンパニオン診断テスト市場動向 ・主要企業別マーケットシェア ・腫瘍学におけるコンパニオン診断テストの種類別市場規模2014-2019 （タンパク質検出、DNA検出） ・腫瘍学におけるコンパニオン診断テストの用途別市場規模2014-2019 （製薬・バイオテクノロジー企業、医療機器企業、研究機関） ・腫瘍学におけるコンパニオン診断テストの北米市場：主要企業・種類別/用途別市場規模 ・腫瘍学におけるコンパニオン診断テストのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・腫瘍学におけるコンパニオン診断テストの中国市場：主要企業・種類別/用途別市場規模 ・腫瘍学におけるコンパニオン診断テストの日本国内市場：主要企業・種類別/用途別市場規模 ・腫瘍学におけるコンパニオン診断テストの東南アジア市場：主要企業・種類別/用途別市場規模 ・腫瘍学におけるコンパニオン診断テストのインド市場：主要企業・種類別/用途別市場規模 ・腫瘍学におけるコンパニオン診断テストの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott、Roche、Genomic Health、QIAGEN、Agilent、Agendia、BioMerieux、Illumina、Siemens Healthcare、Thermo Fisher） ・腫瘍学におけるコンパニオン診断テストの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.In 2018, the global Companion Diagnostic Tests in Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Companion Diagnostic Tests in Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Tests in Oncology development in United States, Europe and China.

The key players covered in this study
Abbott
Roche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare
Thermo Fisher

Market segment by Type, the product can be split into
Protein Detection
DNA Detection

Market segment by Application, split into
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Companion Diagnostic Tests in Oncology status, future forecast, growth opportunity, key market and key players.
To present the Companion Diagnostic Tests in Oncology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Companion Diagnostic Tests in Oncology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (2014-2025)
1.4.2 Protein Detection
1.4.3 DNA Detection
1.5 Market by Application
1.5.1 Global Companion Diagnostic Tests in Oncology Market Share by Application (2014-2025)
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 Medical Device Companies
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Companion Diagnostic Tests in Oncology Market Size
2.2 Companion Diagnostic Tests in Oncology Growth Trends by Regions
2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions (2014-2025)
2.2.2 Companion Diagnostic Tests in Oncology Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Companion Diagnostic Tests in Oncology Market Size by Manufacturers
3.1.1 Global Companion Diagnostic Tests in Oncology Revenue by Manufacturers (2014-2019)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served
3.3 Key Players Companion Diagnostic Tests in Oncology Product/Solution/Service
3.4 Date of Enter into Companion Diagnostic Tests in Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019)
4.2 Global Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019)

5 United States
5.1 United States Companion Diagnostic Tests in Oncology Market Size (2014-2019)
5.2 Companion Diagnostic Tests in Oncology Key Players in United States
5.3 United States Companion Diagnostic Tests in Oncology Market Size by Type
5.4 United States Companion Diagnostic Tests in Oncology Market Size by Application

6 Europe
6.1 Europe Companion Diagnostic Tests in Oncology Market Size (2014-2019)
6.2 Companion Diagnostic Tests in Oncology Key Players in Europe
6.3 Europe Companion Diagnostic Tests in Oncology Market Size by Type
6.4 Europe Companion Diagnostic Tests in Oncology Market Size by Application

7 China
7.1 China Companion Diagnostic Tests in Oncology Market Size (2014-2019)
7.2 Companion Diagnostic Tests in Oncology Key Players in China
7.3 China Companion Diagnostic Tests in Oncology Market Size by Type
7.4 China Companion Diagnostic Tests in Oncology Market Size by Application

8 Japan
8.1 Japan Companion Diagnostic Tests in Oncology Market Size (2014-2019)
8.2 Companion Diagnostic Tests in Oncology Key Players in Japan
8.3 Japan Companion Diagnostic Tests in Oncology Market Size by Type
8.4 Japan Companion Diagnostic Tests in Oncology Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2014-2019)
9.2 Companion Diagnostic Tests in Oncology Key Players in Southeast Asia
9.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type
9.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application

10 India
10.1 India Companion Diagnostic Tests in Oncology Market Size (2014-2019)
10.2 Companion Diagnostic Tests in Oncology Key Players in India
10.3 India Companion Diagnostic Tests in Oncology Market Size by Type
10.4 India Companion Diagnostic Tests in Oncology Market Size by Application

11 Central & South America
11.1 Central & South America Companion Diagnostic Tests in Oncology Market Size (2014-2019)
11.2 Companion Diagnostic Tests in Oncology Key Players in Central & South America
11.3 Central & South America Companion Diagnostic Tests in Oncology Market Size by Type
11.4 Central & South America Companion Diagnostic Tests in Oncology Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Companion Diagnostic Tests in Oncology Introduction
12.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Companion Diagnostic Tests in Oncology Introduction
12.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Genomic Health
12.3.1 Genomic Health Company Details
12.3.2 Company Description and Business Overview
12.3.3 Companion Diagnostic Tests in Oncology Introduction
12.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.3.5 Genomic Health Recent Development
12.4 QIAGEN
12.4.1 QIAGEN Company Details
12.4.2 Company Description and Business Overview
12.4.3 Companion Diagnostic Tests in Oncology Introduction
12.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.4.5 QIAGEN Recent Development
12.5 Agilent
12.5.1 Agilent Company Details
12.5.2 Company Description and Business Overview
12.5.3 Companion Diagnostic Tests in Oncology Introduction
12.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.5.5 Agilent Recent Development
12.6 Agendia
12.6.1 Agendia Company Details
12.6.2 Company Description and Business Overview
12.6.3 Companion Diagnostic Tests in Oncology Introduction
12.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.6.5 Agendia Recent Development
12.7 BioMerieux
12.7.1 BioMerieux Company Details
12.7.2 Company Description and Business Overview
12.7.3 Companion Diagnostic Tests in Oncology Introduction
12.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.7.5 BioMerieux Recent Development
12.8 Illumina
12.8.1 Illumina Company Details
12.8.2 Company Description and Business Overview
12.8.3 Companion Diagnostic Tests in Oncology Introduction
12.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.8.5 Illumina Recent Development
12.9 Siemens Healthcare
12.9.1 Siemens Healthcare Company Details
12.9.2 Company Description and Business Overview
12.9.3 Companion Diagnostic Tests in Oncology Introduction
12.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.9.5 Siemens Healthcare Recent Development
12.10 Thermo Fisher
12.10.1 Thermo Fisher Company Details
12.10.2 Company Description and Business Overview
12.10.3 Companion Diagnostic Tests in Oncology Introduction
12.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)
12.10.5 Thermo Fisher Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Companion Diagnostic Tests in Oncology Key Market Segments
Table Key Players Companion Diagnostic Tests in Oncology Covered
Table Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type 2014-2025
Figure Protein Detection Figures
Table Key Players of Protein Detection
Figure DNA Detection Figures
Table Key Players of DNA Detection
Table Global Companion Diagnostic Tests in Oncology Market Size Growth by Application 2014-2025 (Million US$)
Figure Pharmaceutical & Biotechnology Companies Case Studies
Figure Medical Device Companies Case Studies
Figure Research Institutes Case Studies
Figure Companion Diagnostic Tests in Oncology Report Years Considered
Table Global Companion Diagnostic Tests in Oncology Market Size 2014-2025 (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size by Regions 2014-2025 (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size by Regions 2014-2019 (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Share by Regions 2014-2019
Figure Global Companion Diagnostic Tests in Oncology Market Share by Regions 2014-2019
Figure Global Companion Diagnostic Tests in Oncology Market Share by Regions 2019
Table Market Top Trends
Table Global Companion Diagnostic Tests in Oncology Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Share by Manufacturers (2014-2019)
Figure Global Companion Diagnostic Tests in Oncology Market Share by Manufacturers in 2018
Table Global Companion Diagnostic Tests in Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Companion Diagnostic Tests in Oncology Product/Solution/Service
Table Date of Enter into Companion Diagnostic Tests in Oncology Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019) (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2014-2019)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2014-2019)
Table Global Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2014-2019)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2014-2019)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application in 2018
Figure United States Companion Diagnostic Tests in Oncology Market Size 2014-2019 (Million US$)
Table United States Key Players Companion Diagnostic Tests in Oncology Revenue (2018-2019) (Million US$)
Table United States Key Players Companion Diagnostic Tests in Oncology Market Share (2018-2019)
Table United States Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019) (Million US$)
Table United States Companion Diagnostic Tests in Oncology Market Share by Type (2014-2019)
Table United States Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table United States Companion Diagnostic Tests in Oncology Market Share by Application (2014-2019)
Figure Europe Companion Diagnostic Tests in Oncology Market Size 2014-2019 (Million US$)
Table Europe Key Players Companion Diagnostic Tests in Oncology Revenue (2018-2019) (Million US$)
Table Europe Key Players Companion Diagnostic Tests in Oncology Market Share (2018-2019)
Table Europe Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019) (Million US$)
Table Europe Companion Diagnostic Tests in Oncology Market Share by Type (2014-2019)
Table Europe Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table Europe Companion Diagnostic Tests in Oncology Market Share by Application (2014-2019)
Figure China Companion Diagnostic Tests in Oncology Market Size 2014-2019 (Million US$)
Table China Key Players Companion Diagnostic Tests in Oncology Revenue (2018-2019) (Million US$)
Table China Key Players Companion Diagnostic Tests in Oncology Market Share (2018-2019)
Table China Companion Diagnostic Tests in Oncology Market Size by Type (2014-20189) (Million US$)
Table China Companion Diagnostic Tests in Oncology Market Share by Type (2014-2019)
Table China Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table China Companion Diagnostic Tests in Oncology Market Share by Application (2014-2019)
Figure Japan Companion Diagnostic Tests in Oncology Market Size 2014-2019 (Million US$)
Table Japan Key Players Companion Diagnostic Tests in Oncology Revenue (2018-2019) (Million US$)
Table Japan Key Players Companion Diagnostic Tests in Oncology Market Share (2018-2019)
Table Japan Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019) (Million US$)
Table Japan Companion Diagnostic Tests in Oncology Market Share by Type (2014-2019)
Table Japan Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table Japan Companion Diagnostic Tests in Oncology Market Share by Application (2014-2019)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Companion Diagnostic Tests in Oncology Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Companion Diagnostic Tests in Oncology Market Share (2018-2019)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2014-2019)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2014-2019)
Figure India Companion Diagnostic Tests in Oncology Market Size 2014-2019 (Million US$)
Table India Key Players Companion Diagnostic Tests in Oncology Revenue (2018-2019) (Million US$)
Table India Key Players Companion Diagnostic Tests in Oncology Market Share (2018-2019)
Table India Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019) (Million US$)
Table India Companion Diagnostic Tests in Oncology Market Share by Type (2014-2019)
Table India Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table India Companion Diagnostic Tests in Oncology Market Share by Application (2014-2019)
Figure Central & South America Companion Diagnostic Tests in Oncology Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Companion Diagnostic Tests in Oncology Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Companion Diagnostic Tests in Oncology Market Share (2018-2019)
Table Central & South America Companion Diagnostic Tests in Oncology Market Size by Type (2014-2019) (Million US$)
Table Central & South America Companion Diagnostic Tests in Oncology Market Share by Type (2014-2019)
Table Central & South America Companion Diagnostic Tests in Oncology Market Size by Application (2014-2019) (Million US$)
Table Central & South America Companion Diagnostic Tests in Oncology Market Share by Application (2014-2019)
Table Abbott Company Details
Table Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019) (Million US$)
Figure Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Abbott Recent Development
Table Roche Company Details
Table Roche Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Roche Recent Development
Table Genomic Health Company Details
Table Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Genomic Health Recent Development
Table QIAGEN Company Details
Table QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table QIAGEN Recent Development
Table Agilent Company Details
Table Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Agilent Recent Development
Table Agendia Company Details
Table Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Agendia Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table BioMerieux Recent Development
Table Illumina Company Details
Table Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Illumina Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Siemens Healthcare Recent Development
Table Thermo Fisher Company Details
Table Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2014-2019)(Million US$)
Figure Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2014-2019)
Table Thermo Fisher Recent Development
Table Global Companion Diagnostic Tests in Oncology Market Size by Regions (Million US$) 2019-2025
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions (2019-2025)
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions in 2025
Figure United States Companion Diagnostic Tests in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Europe Companion Diagnostic Tests in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure China Companion Diagnostic Tests in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Japan Companion Diagnostic Tests in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure India Companion Diagnostic Tests in Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Companion Diagnostic Tests in Oncology Market Size Forecast (2019-2025)(Million USD)
Table Global Companion Diagnostic Tests in Oncology Market Size by Product (2019-2025) (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Product (2019-2025)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Product in 2025
Table Global Companion Diagnostic Tests in Oncology Market Size by Application (2019-2025) (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Application (2019-2025)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---